Blog

Interested in recent clinical trial news and information on clinical trial services?

Keep up to date with our blogs.

How is Automation Helping to Optimise Clinical Trials?

December 2017

Clinical trials are growing increasingly complex, which means they’re likely to cost more and take up a lot of time for professionals and patients alike. The average clinical phase duration of drug development is now estimated at 6.8 years, a 15% increase over levels observed 10 years ago. Technological advances and the inclusion of more […]

View full article

Boosting Clinical Trial Recruitment

November 2017

At Client-Pharma, we know that recruiting patients to participate in clinical trials isn’t always easy. There are many barriers that can affect clinical trial recruitment, including the way patients think about clinical trials in the first place. This may be due to incorrect information or a lack of awareness. What are some ways that clinical […]

View full article

How is New Technology Affecting Clinical Trials Services?

October 2017

Technology is changing the face of clinical trials services, making them faster, less expensive and more accessible to participants around the world. With emerging and evolving software and an ever-growing digital focus, the event of a shift in the way the industry views clinical trial services is just around the corner. It’s important to remember […]

View full article

The Future of Clinical Trials – What Can We Predict?

September 2017

Clinical trials are constantly evolving, with more data being collected in reflection to an increasingly complex environment. New technology, regulations, legislation and reforms in the pharmaceutical sector result in an environment that is always evolving. What does the future hold for clinical trials and what changes can we expect? Siteless Clinical Trials Siteless clinical trials […]

View full article

How Will Reforms Change the Landscape of China’s Clinical Trials?

August 2017

China’s central government have introduced reforms in response to an increasingly challenging regulatory environment. These are likely to benefit medicine access as well as drug development, affecting those looking into China’s pharmaceutical market, which is the second largest in the world. In a long-awaited response to feedback from the local and international pharmaceutical industry, the […]

View full article